[31B1-31B1];[31D9-31D9];
A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
31B1;31D9
Breakpoint from FlyBase's release 5 sequence location of progenitor insertion.
The stock contains a second-site deletion uncovering l(2)gl.
Presence of P+PBac{XP5.WH5}BSC143 was verified using the PCR methods and primers described in FBrf0175003.
The cytological breakpoints of Df(2L)BSC143 predicted from the transposable element insertions sites using Release 3 coordinates are 31B1;31D9.